Torre, Guillermo — Insider Profile

Insider Profile

Torre, Guillermo

$CRDL

Companies Filed At

Open-Market Buys (2yr)

$50K

Buy Value (2yr, open-market)

Dec 30, 2025

Most Recent Trade

Credibility
Score

15%

Hit Rate

-10.8%

Avg 90d Return

-11.9%

Median 90d Return

Evaluated Trades

+55.3%

Best Trade

-51.8%

Worst Trade

Hit rate and returns are based on 13 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Dec 30, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	23,515	—	—	45
Dec 03, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	60,000	$1.00	$60K	45
Oct 17, 2025	$CRDL Cardiol Therapeutics Inc	—	Open Market	Sell	25,000	$1.35	$34K	45
Oct 17, 2025	$CRDL Cardiol Therapeutics Inc	—	Open Market	Sell	50,000	$1.00	$50K	45
Sep 30, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	21,951	—	—	45
Sep 30, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	21,951	—	—	45
Sep 30, 2025	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	21,591	—	—	45
Dec 26, 2024	$CRDL Cardiol Therapeutics Inc	—	Open Market	Buy	17,240	$1.26	$22K	45
Dec 18, 2024	$CRDL Cardiol Therapeutics Inc	—	Open Market	Buy	919	$1.45	$1K	45
Dec 17, 2024	$CRDL Cardiol Therapeutics Inc	—	Open Market	Buy	19,880	$1.31	$26K	45
Dec 16, 2024	$CRDL Cardiol Therapeutics Inc	—	Open Market	Buy	749	$1.33	$1,000	45
Jul 10, 2024	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	100,000	—	—	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Expiry	Sell	60,000	$5.00	$300K	45
Sep 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Comp. Grant	Buy	68,157	$1.41	$96K	45
Mar 31, 2022	$CRDL Cardiol Therapeutics Inc	—	Open Market	Buy	47,000	$1.46	$69K	45
Mar 30, 2022	$CRDL Cardiol Therapeutics Inc	—	Open Market	Buy	19,800	$1.44	$28K	45
Mar 31, 2021	$CRDL Cardiol Therapeutics Inc	—	Other	Buy	2,478	$4.54	$11K	45
Jan 11, 2021	$CRDL Cardiol Therapeutics Inc	—	Other	Buy	12,054	$2.80	$34K	45

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Signal scores reflect the company's current score, not the score at time of trade.